ADVB
Advanced Biomed Inc.
Key Financials
Net Income
$-3258969
↓ 17.1%
Total Assets
$6.5M
↑ 46.0%
Total Liabilities
$3.0M
↑ 8.5%
EPS (Diluted)
$-0.16
↓ 14.3%
Shareholders' Equity
$3.5M
↑ 109.1%
Operating Cash Flow
$-5825055.00
↓ 173.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-K | 9/28/2026 | View on SEC |
| SCHEDULE 13G | 9/22/2026 | View on SEC |
| 4 | 8/20/2026 | View on SEC |
| SCHEDULE 13G/A | 8/20/2026 | View on SEC |
| SCHEDULE 13G | 8/20/2026 | View on SEC |
| RW | 7/20/2026 | View on SEC |
| 8-K | 7/17/2026 | View on SEC |
| 8-K | 7/1/2026 | View on SEC |
| 8-K | 6/30/2026 | View on SEC |
| DEF 14A | 6/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ADVB |
| Company Name | Advanced Biomed Inc. |
| CIK | 1941029 |
| Sector | Services-Medical Laboratories |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | NV |
| Phone | 86-21-20510823 |